	Oncogenic role and potential mechanisms of MYO1B in breast cancer. In Vitro Cell Dev Biol Anim Dai M, Jiang Q, Zhang D, Li L. PMID: 41986768 [PubMed - as supplied by publisher]
	Disparities in blood cancer survival in the UK 2009-2019: national cohort studies. BJC Rep Hoang J, Allen J, Capel R, Thomas R, Smits S, Ahmed R, Webb H, Sheikh A, Cox S, Bygrave C, Hippisley-Cox J. PMID: 41986693 [PubMed]
	Giant cancer study reveals effectiveness of 'off label' treatments. Nature Thompson B. PMID: 41986686 [PubMed - as supplied by publisher]
	Correction: Prospective study on (18)F-FDG PET-CT for staging locally advanced invasive lobular breast carcinoma. Br J Cancer Metser U, Dayes IS, Parpia S, Eisen AF, Hodgson N, Cil TD, George R, Blanchette P, Arnaout A, Chan A, Levine MN. PMID: 41986662 [PubMed - as supplied by publisher]
	Tumour promotion through the lens of evolution. Nature Lopez-Bigas N, Kandyba E, Gonzalez-Perez A, Brennan P, Balmain A. PMID: 41986628 [PubMed - in process]
	A mechanism for adaptive genome regulation in cancer. Nature França GS, Yanai I. PMID: 41986626 [PubMed - in process]
	Beyond breast cancer: mapping unmet needs and advancing an evidence-based framework of survivorship care. Support Care Cancer Silva A, Dupuis KL, Pourrajabi A, Kulawic K, Galica J, Teggart K, Abolhasani R, Lino M, Schumacher C, Hayward S, Taplay K, Giroux J, Stark D, Carroll B, Luctkar-Flude M, Winters E, Conception J, Silva VSE. PMID: 41986578 [PubMed - indexed for MEDLINE]
	The effect of thunder-fire moxibustion on cancer-related fatigue in patients with Qi stagnation and blood stasis type colorectal cancer undergoing chemotherapy: a randomized controlled trial. Support Care Cancer Xiaobing Y, Qidi L, Liyan L, Bin S, Yanyan H, Li B, Sixuan H. PMID: 41986533 [PubMed - indexed for MEDLINE]
	Predictive value of early PSMA upregulation for the response to enzalutamideâ€‰Â±â€‰(177)Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer: substudy of the randomized, phase 2 ENZA-p trial. Nat Cancer Emmett L, Swiha M, Papa N, Subramaniam S, Crumbaker M, Joshua AM, Nguyen A, Weickhardt A, Lee ST, Ng S, Francis RJ, Goh JC, Pattison DA, Pathmanandavel S, Hope T, Ayati N, Hofman MS, Sandhu S, Niu C, Martin AJ, Thomas H, Stockler MR, Davis ID, Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group. PMID: 41986500 [PubMed - as supplied by publisher]
	FT-MDNNMDs: early detection of breast cancer using fine-tuned multi-deep neural networks with TCGA and clinical image datasets. Sci Rep Shafique A, Mehmood A, Al-Qudah R, Zakaria K. PMID: 41986442 [PubMed - as supplied by publisher]
	Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial. Nat Commun Huff AL, Haldar SD, Girgis AA, Wang HH, Danilova L, Heumann T, Berg M, Wang Y, Andaloori L, Hernandez A, Longway G, Barrett B, Zhu Z, Davis-Marcisak E, Thoburn C, Leatherman J, Mitchell S, Lee JW, Shu DH, Konig MF, Mog BJ, Montagne J, Coyne EM, Bever K, Baretti M, Yarchoan M, Anders RA, Kagohara LT, Laheru D, Thomas AM, Durham J, Nauroth JM, Lu J, Wang H, Fertig EJ, Ho WJ, Azad NS, Jaffee EM, Zaidi N. PMID: 41986375 [PubMed - in process]
	Esophageal cancer: from pathogenesis to precision therapies. Signal Transduct Target Ther Zhang S, Shen Y, Zhu L, Lai Y, Zhu L, Xiao X, Li J, Tan W, Lin D, Wu C. PMID: 41986343 [PubMed - indexed for MEDLINE]
	HDAC inhibitor tucidinostat and metronomic capecitabine plus endocrine therapy for patients with HR-positive HER2-negative advanced breast cancer after CDK4/6 inhibitors treatment: clinical findings and exploratory circulating tumor cell and ctDNA biomarker analyses of a multicenter, phase 2 study (SYSUCC-020 trial). Signal Transduct Target Ther Wu HL, Xia W, Xu Z, Zhou H, Chen L, Lu Y, Liu X, Pang D, Liu Y, Lu Q, Xu F, An X, Huang J, Jiang K, Zhang J, Cai Y, Hong R, Zheng Q, Wang S. PMID: 41986320 [PubMed - indexed for MEDLINE]
	Endoplasmic reticulum stress in disease pathogenesis: its implications for therapy. Signal Transduct Target Ther Wei S, Zhang N, Zhang H, Chen Z, Li S, Wu W, Liu Z, Xia Z, Luo P, Cheng Q. PMID: 41986307 [PubMed - indexed for MEDLINE]
	Response to comments on "Predictive machine learning algorithms for depression and anxiety disorders in six cancer types: a comprehensive multi-center population-based study". J Formos Med Assoc Shi HY. PMID: 41986222 [PubMed - as supplied by publisher]
	Imaging Immune Heterogeneity in Nasopharyngeal Carcinoma: A Multidimensional Radiomics Perspective. Acad Radiol Liang J, Wang Z, Zhang Y. PMID: 41986218 [PubMed - as supplied by publisher]
	Letter to the Editor Regarding "Real-World Characteristics, Treatment Patterns, and Outcomes in Advanced HER2 (ERBB2)-Mutant Non-Small Cell Lung Cancer: A Retrospective Study of Single Centers in France and Germany". Clin Ther Xu L, Tong X, Yu D. PMID: 41986206 [PubMed - as supplied by publisher]
	Toward organ preservation in thoracic malignancies: why interpretable multimodal radiopathomics matters in the neoadjuvant immunotherapy era. J Immunother Cancer Jiang W, Fan Y, Zhao J, Zeng J, Wu L. PMID: 41986074 [PubMed - indexed for MEDLINE]
	Transverse myelitis as an initial presentation of sarcoidosis. BMJ Case Rep Santos V, Movio G, Mohan A, McLellan T. PMID: 41986067 [PubMed - indexed for MEDLINE]
	Metastatic rosette-forming glioneuronal tumour presenting as isolated primary amenorrhoea. BMJ Case Rep Gabriel M, Pohl U, Kamran HS, Hanasoge R, Govindan J. PMID: 41986065 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 1927023

Page 1 of 96352



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy